Table 1.
HCV subtype and response upon treatment
| Time line | Case 1 (Genotype la) | Case 2 (Genotype 2b) |
|---|---|---|
| 0 weeks | Treatment started | Treatment started |
| 12 weeks | VL∗ – undetectable | VL-undetectable |
| 16 weeks | Vitiligo at injection site | NA |
| 20 weeks | Vitiligo at injection site | Vitiligo at injection site |
| 24 weeks | Vitiligo at injection site | Vitiligo at injection and surrounding site |
| VL-not reported | VL-undetectable | |
| 48 weeks | Vitiligo at injection site | Vitiligo at injection and surrounding site |
| VL-undetectable | VL-not reported | |
| 6 months | Vitiligo at injection site | More diffuse Vitiligo |
| VL-detectable | VL-undetectable | |
| Host immune response | Weak | Strong |
∗
Viral load.